The US embassy in India has issued a strong statement after revoking several US Visas linked to drug trafficking cases.
Visa Cancellations Linked to Fentanyl Precursors
Reports say multiple Indian business executives and their families were affected due to alleged involvement in fentanyl precursor trafficking. India and China are increasingly identified as key sources of fentanyl and its components.
Rising Fentanyl Crisis in the US
Fentanyl is nearly 50 times more powerful than heroin and caused more than 48,000 overdose deaths in the US last year. The crisis has prompted stricter enforcement measures and closer monitoring of global supply chains.
Decision Under Immigration Law
The US Embassy in New Delhi confirmed the decision was made under the Immigration and Nationality Act. However, it did not disclose the names of the executives or the companies involved in the crackdown.
Warning to Indian Pharmaceutical Industry
While praising India’s cooperation, the embassy warned violators and other companies in the same sector. Indian pharma exports may now face more scrutiny, and existing regulatory agreements may not be enough to reassure US authorities.
Economic and Trade Concerns
Analysts caution that legitimate pharmaceutical firms could face economic and reputational damage. They warn that visa revocations and tighter checks could have ripple effects on pharma trade between India and the US.
Debate Over Public Health Approach
Some experts argue that focusing only on enforcement ignores the public health aspect of the opioid crisis. However, the US embassy appears determined to continue with strict action.
